-

Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research

Partnership enhances oncology clinical trial efficiency through streamlined technology integration and long-term strategic collaboration.

NEW YORK--(BUSINESS WIRE)--Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, today announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry. As part of the partnership, Flatiron Health will join the Veeva Product Partner Program.

Flatiron and Veeva customers utilizing Flatiron Clinical Pipe™ will benefit from accelerated deployment and continually optimized configurations, ensuring seamless performance and a well-supported experience to meet evolving needs.

Share

This collaboration builds on the integration of Flatiron Clinical Pipe™ and Veeva EDC (Electronic Data Capture), enhancing value and experience for both research sites and sponsor customers. As a cutting-edge EHR-to-EDC connector, Flatiron Clinical Pipe™ eliminates manual data entry of structured and unstructured data—improving site workflows, lowering data monitoring costs, and accelerating study timelines. Through this partnership, Flatiron and Veeva customers utilizing Flatiron Clinical Pipe™ will benefit from accelerated deployment and continually optimized configurations, ensuring seamless performance and a well-supported experience to meet evolving needs.

“Our collaboration with Veeva strengthens Flatiron’s ecosystem of partners in clinical research, reinforcing our position as an innovator in the use of technology to streamline clinical trials,” said Alex Deyle, General Manager of Clinical Research at Flatiron Health. “Flatiron Clinical Pipe, integrated with Veeva EDC, enables more streamlined data acquisition for clinical trials across a broader set of both research sites and sponsors—ultimately reducing burden, driving operational efficiencies, and accelerating research timelines.”

Additionally, the partnership establishes a long-term forum for strategic collaboration, allowing both companies to align on future innovations that streamline clinical trial data acquisition and drive greater value for customers.

Research published in the journal ESMO Real World Data and Digital Oncology, found that clinical research teams using Flatiron Clinical Pipe™ were able to accurately transfer thousands of data points, representing completion of hundreds of case report forms (CRF), with the average time of 37 seconds for a user to launch, complete, and submit a CRF, representing significant time savings for data entry over the course of a trial.1 Data transferred to the EDC with Flatiron Clinical Pipe™ completely mirrors source data in the EHR, reducing the need for source data verification on transferred data, allowing for greater efficiency for study teams.

About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth

  1. Utility of automated data transfer for cancer clinical trials and considerations for implementation. Pfeffer, M. et al. ESMO Real World Data and Digital Oncology, Volume 7, 100112. DOI: 10.1016/j.esmorw.2025.100112

 

Contacts

Flatiron Health
Nina Toor
press@flatiron.com

Flatiron Health

Details
Headquarters: New York, NY
CEO: Nathan Hubbard
Employees: 2,500
Organization: PRI

Release Versions

Contacts

Flatiron Health
Nina Toor
press@flatiron.com

Social Media Profiles
More News From Flatiron Health

Flatiron Health Expands NSCLC Panoramic Dataset With Comprehensive Biomarker Data Model, Enabling Precision Medicine Research at Unprecedented Scale

NEW YORK--(BUSINESS WIRE)--Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the expansion of its non-small cell lung cancer (NSCLC) Panoramic dataset with a comprehensive biomarker data model, delivering specimen-level molecular detail at a scale of 345,000+ patients across early and advanced settings. This expansion enables researchers to more deeply explore biomarker-driven treatment patterns, patien...

Flatiron Health Brings Three Research Acceptances to WCLC 2026

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the IASLC 2026 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer, with three research acceptances highlighting real-world evidence that advances precision medicine and treatment optimization in non-small cell lung cancer (NSCLC). The presentations demonstrate how Flatiron's high-quality, longitudinal data reveals clinical insights that shape oncology decision-making acro...

Flatiron Health Expands Global Oncology Network Through First Partnership in Scotland

NEW YORK--(BUSINESS WIRE)--Flatiron Health, a global healthcare technology company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced a new partnership between Flatiron Health UK and NHS Greater Glasgow and Clyde (NHSGGC), the largest health board in Scotland. The collaboration marks Flatiron's first partnership in Scotland and further expands its growing international oncology network across the UK, Germany, and Japan. Through the partnership...
Back to Newsroom